BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29740587)

  • 1. The Effect of Anatomical Location of Lymph Node Metastases on Cancer Specific Survival in Patients with Clear Cell Renal Cell Carcinoma.
    Nini A; Larcher A; Cianflone F; Trevisani F; Terrone C; Volpe A; Regis F; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U
    Front Surg; 2018; 5():26. PubMed ID: 29740587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy.
    Rosiello G; Scilipoti P; Larcher A; Fallara G; Colandrea G; Basile G; Re C; Tian Z; Karakiewicz PI; Mottrie A; Trevisani F; Marandino L; Raggi D; Necchi A; Bertini R; Salonia A; Briganti A; Montorsi F; Capitanio U
    World J Urol; 2023 Jun; 41(6):1573-1579. PubMed ID: 37148324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topographic distribution of first landing sites of lymphatic metastases from patients with renal cancer.
    Kuusk T; Zondervan P; Lagerveld B; Rosenzweig B; Raman A; Blok JM; de Bruijn R; Graafland N; Hendricksen K; Capitanio U; Minervini A; Ljungberg B; Horenblas S; Bex A
    Urol Oncol; 2020 May; 38(5):521-525. PubMed ID: 32139289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    J Urol; 2017 Mar; 197(3 Pt 1):574-579. PubMed ID: 27663461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
    Tilki D; Chandrasekar T; Capitanio U; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Linares Espinós E; Lorentz A; Martinez-Salamanca JI; Master VA; McKiernan JM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Rodriguez-Faba O; Russo P; Scherr DS; Shariat SF; Spahn M; Terrone C; Vera-Donoso C; Zigeuner R; Libertino JA; Evans CP
    Urol Oncol; 2018 Feb; 36(2):79.e11-79.e17. PubMed ID: 29129353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study.
    Dorin RP; Daneshmand S; Eisenberg MS; Chandrasoma S; Cai J; Miranda G; Nichols PW; Skinner DG; Skinner EC
    Eur Urol; 2011 Nov; 60(5):946-52. PubMed ID: 21802833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.
    Tarin TV; Power NE; Ehdaie B; Sfakianos JP; Silberstein JL; Savage CJ; Sjoberg D; Dalbagni G; Bochner BH
    Eur Urol; 2012 May; 61(5):1025-30. PubMed ID: 22342773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
    Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
    J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy.
    Yang DY; Potretzke TA; Miest TS; Bhindi B; Lohse CM; Cheville JC; King BF; Boorjian SA; Leibovich BC; Thompson RH; Potretzke AM
    Int J Urol; 2020 Jul; 27(7):618-622. PubMed ID: 32424856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer.
    Abdollah F; Gandaglia G; Suardi N; Capitanio U; Salonia A; Nini A; Moschini M; Sun M; Karakiewicz PI; Shariat SF; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):212-9. PubMed ID: 24882672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Positive Lymph Nodes in Patients with Renal Cell Carcinoma and Tumor Thrombus Undergoing Nephrectomy and Thrombectomy.
    Xiao R; Xu C; Ge L; He W; Yang B; Liu L; Liu C; Ma L
    Urol Int; 2021; 105(7-8):657-665. PubMed ID: 33882508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model.
    Gershman B; Takahashi N; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    BJU Int; 2016 Nov; 118(5):742-749. PubMed ID: 26800148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of renal cell carcinoma with isolated lymph node metastases following surgical resection from 2006 to 2013.
    Golijanin B; Pereira J; Mueller-Leonhard C; Golijanin D; Amin A; Mega A; Boorjian SA; Thompson RH; Leibovich BC; Gershman B
    Urol Oncol; 2019 Dec; 37(12):932-940. PubMed ID: 31570248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after resection of occult and non-occult lymph node metastases at the time of nephrectomy.
    Kuusk T; Klatte T; Zondervan P; Lagerveld B; Graafland N; Hendricksen K; Capitanio U; Minervini A; Stewart GD; Ljungberg B; Horenblas S; Bex A
    World J Urol; 2021 Sep; 39(9):3377-3383. PubMed ID: 33634323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
    BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
    Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC
    J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
    Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.